Literature DB >> 12505295

Guidelines for application of chemical-specific adjustment factors in dose/concentration-response assessment.

M E Meek1, A Renwick, E Ohanian, M Dourson, B Lake, B D Naumann, V Vu.   

Abstract

This manuscript addresses guidance in the use of kinetic and dynamic data to inform quantitatively extrapolations for interspecies differences and human variability in dose-response assessment developed in a project of the International Programme on Chemical Safety (IPCS) initiative on Harmonisation of Approaches to the Assessment of Risk from Exposure to Chemicals. The guidance has been developed and refined through a series of planning and technical meetings and larger workshops of a broad range of participants from academia, government agencies and the private sector. The guidance for adequacy of data for replacement of common defaults for interspecies differences and human variability is presented in the context of several generic categories including: determination of the active chemical species, choice of the appropriate metric (kinetic components) or endpoint (dynamic components) and nature of experimental data, the latter which includes reference to the relevance of population, route and dose and the adequacy of the number of subjects/samples. The principal objective of this guidance developed primarily as a resource for risk assessors, is to foster better understanding of the components of and criteria for adequacy of chemical-specific data to quantitate interspecies differences and human variability in kinetics and dynamics. It is anticipated that this guidance will also encourage the development of appropriate data and facilitate their incorporation in a consistent fashion in dose-response assessment for regulatory purposes (IPCS, 2001).

Entities:  

Mesh:

Year:  2002        PMID: 12505295     DOI: 10.1016/s0300-483x(02)00265-2

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  10 in total

1.  A Bayesian Method for Population-wide Cardiotoxicity Hazard and Risk Characterization Using an In Vitro Human Model.

Authors:  Alexander D Blanchette; Sarah D Burnett; Fabian A Grimm; Ivan Rusyn; Weihsueh A Chiu
Journal:  Toxicol Sci       Date:  2020-12-01       Impact factor: 4.849

Review 2.  Model systems and organisms for addressing inter- and intra-species variability in risk assessment.

Authors:  Ivan Rusyn; Weihsueh A Chiu; Fred A Wright
Journal:  Regul Toxicol Pharmacol       Date:  2022-05-28       Impact factor: 3.598

3.  Update on a Pharmacokinetic-Centric Alternative Tier II Program for MMT-Part II: Physiologically Based Pharmacokinetic Modeling and Manganese Risk Assessment.

Authors:  Michael D Taylor; Harvey J Clewell; Melvin E Andersen; Jeffry D Schroeter; Miyoung Yoon; Athena M Keene; David C Dorman
Journal:  J Toxicol       Date:  2012-05-07

4.  An assessment of the interindividual variability of internal dosimetry during multi-route exposure to drinking water contaminants.

Authors:  Mathieu Valcke; Kannan Krishnan
Journal:  Int J Environ Res Public Health       Date:  2010-11-17       Impact factor: 3.390

5.  Kinetics of ethylene and ethylene oxide in subcellular fractions of lungs and livers of male B6C3F1 mice and male fischer 344 rats and of human livers.

Authors:  Qiang Li; György András Csanády; Winfried Kessler; Dominik Klein; Helmut Pankratz; Christian Pütz; Nadine Richter; Johannes Georg Filser
Journal:  Toxicol Sci       Date:  2011-07-23       Impact factor: 4.849

6.  Modeling the Human Kinetic Adjustment Factor for Inhaled Volatile Organic Chemicals: Whole Population Approach versus Distinct Subpopulation Approach.

Authors:  M Valcke; A Nong; K Krishnan
Journal:  J Toxicol       Date:  2012-03-07

7.  Application of key events analysis to chemical carcinogens and noncarcinogens.

Authors:  Alan R Boobis; George P Daston; R Julian Preston; Stephen S Olin
Journal:  Crit Rev Food Sci Nutr       Date:  2009-09       Impact factor: 11.176

8.  Human induced pluripotent stem cell (iPSC)-derived cardiomyocytes as an in vitro model in toxicology: strengths and weaknesses for hazard identification and risk characterization.

Authors:  Sarah D Burnett; Alexander D Blanchette; Weihsueh A Chiu; Ivan Rusyn
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-03-08       Impact factor: 4.936

Review 9.  Dispelling urban myths about default uncertainty factors in chemical risk assessment--sufficient protection against mixture effects?

Authors:  Olwenn V Martin; Scholze Martin; Andreas Kortenkamp
Journal:  Environ Health       Date:  2013-07-01       Impact factor: 5.984

10.  A human population-based organotypic in vitro model for cardiotoxicity screening.

Authors:  Fabian A Grimm; Alexander Blanchette; John S House; Kyle Ferguson; Nan-Hung Hsieh; Chimeddulam Dalaijamts; Alec A Wright; Blake Anson; Fred A Wright; Weihsueh A Chiu; Ivan Rusyn
Journal:  ALTEX       Date:  2018-07-08       Impact factor: 6.043

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.